External factors
| External factors: |
Melatonin |
| Category: |
Chemical compounds |
| Experiment: |
SA-β-gal activity assay//Flow cytometry |
| Description: |
The percentage of SA-β-gal-positive cells showed a declining dose-dependent tendency in response to melatonin, in which the ratio decreased to 64.7 ± 3.2% at 10 nM, 54.4 ± 2.3% at 1 μM, and 24.3 ± 5.7% at 100 μM . The cell cycle distribution results showed that melatonin-treated BM-MSCs exhibited a significantly increased proportion in the S phase . |
Warning: Undefined variable $target_genes in
/data/html/Aging-ReG/public/browse_detail_2.php on line
385
Regulatory relationship
| Regulatory pathway:
|
SIRT1 |
| R-EF-Pathway:
|
Upregulation |
| Official symbol(s): |
Warning: Undefined variable $name_all in /data/html/Aging-ReG/public/browse_detail_2.php on line 525
SIRT1
|
| Pathway experiment: |
qRT-PCR//Immunofluorescence//Western blot |
| Pathway description: |
On the other hand, treatment with 100 μM melatonin increased the SIRT1 mRNA level by 1.8 ± 0.2-fold higher than the H2O2 group.exposure to H2O2 inhibited SIRT1 protein expression but treatment with melatonin recovered it. Further experiments revealed that the protein level of SIRT1 in H2O2-treated BM-MSCs was significantly down-regulated to 42.8 ± 6.3% compared with the control, but treatment with melatonin upregulated the level of SIRT1. |
Aging network
Annotation:
The green line represents Upregulation.
The purple line represents Downregulation.
The orange line represents Activation.
The yellow line represents Inhibition.
The gray line represents Unclear.